Antiviral Agents against Emerging Viruses
Series: Topics in Medicinal Chemistry;
- Publisher's listprice EUR 299.59
-
117 019 Ft (111 447 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 20% (cc. 23 404 Ft off)
- Discounted price 93 615 Ft (89 158 Ft + 5% VAT)
- Discount is valid until: 30 June 2026
Subcribe now and take benefit of a favourable price.
Subscribe
102 977 Ft
Availability
Not yet published.
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher Springer Nature Switzerland
- Date of Publication 24 July 2026
- ISBN 9783032306197
- Binding Hardback
- No. of pages240 pages
- Size 235x155 mm
- Language English
- Illustrations X, 240 p. 700
Categories
Long description:
This book reviews the current landscape of antiviral drug discovery with a strong focus on viral enzymes as therapeutic targets. It presents a timely, mechanism‐driven overview of approved drugs, clinical candidates, and emerging inhibitor classes developed against major human pathogens, including HIV‐1, SARS‐CoV‐2, West Nile virus, Crimean‐Congo hemorrhagic fever virus, and other hemorrhagic fever viruses. By integrating historical perspectives with recent breakthroughs, the volume highlights both the progress achieved and the challenges that remain in antiviral therapeutics.
The chapters cover key viral targets such as integrase, polymerase, helicase, RNase H, and viral proteases, discussing their structure, function, and role in viral replication. Several contributions focus on SARS‐CoV‐2, addressing polymerase, helicase, and protease inhibitors, while others examine antiviral strategies for flaviviruses and emerging hemorrhagic fever viruses that still lack effective treatments. Together, the chapters provide a coherent overview of target‐based antiviral research across diverse virus families.
This book appeals to researchers, advanced students, and professionals in medicinal chemistry, virology, pharmacology, and drug discovery, as well as to clinicians and translational scientists seeking an up‐to‐date reference on antiviral targets and inhibitor development for both established and emerging viral infections.
MoreTable of Contents:
"
